| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |